Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wanders

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Lung Cancer|December 6, 2003
The relevance of the revised version of the international lung cancer staging system for non-small-cell lung cancer treated with radiotherapyH Langendijk, J de Jong, R Wanders, et al.
Journal of Inherited Metabolic Disease|November 8, 2003
Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2U Spiekerkoetter, G Huener, T Baykal, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 24, 2011
[Sjögren-Larsson syndrome: 2 case reports]C Galoin-Bertail, H Ogier de Baulny, R Wanders, et al.
The Journal of Pediatrics|January 1, 1997
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patientsT Tyni, A Palotie, L Viinikka, et al.
American Journal of Human Genetics|December 18, 1997
Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patientM Huizing, V Iacobazzi, L Ijlst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2008
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based studyD De Ruysscher, A Botterweck, M Dirx, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 2012
Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?D De Ruysscher, J Van Meerbeeck, K Vandecasteele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2010
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)C Le Péchoux, A Laplanche, C Faivre-Finn, et al.
Prenatal Diagnosis|September 3, 2010
Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirthC G Steward, R A Newbury-Ecob, R Hastings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2007
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patientsD De Ruysscher, C Dehing, R-H Bremer, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Lung Cancer|December 6, 2003
The relevance of the revised version of the international lung cancer staging system for non-small-cell lung cancer treated with radiotherapyH Langendijk, J de Jong, R Wanders, et al.
Journal of Inherited Metabolic Disease|November 8, 2003
Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2U Spiekerkoetter, G Huener, T Baykal, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 24, 2011
[Sjögren-Larsson syndrome: 2 case reports]C Galoin-Bertail, H Ogier de Baulny, R Wanders, et al.
The Journal of Pediatrics|January 1, 1997
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patientsT Tyni, A Palotie, L Viinikka, et al.
American Journal of Human Genetics|December 18, 1997
Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patientM Huizing, V Iacobazzi, L Ijlst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2008
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based studyD De Ruysscher, A Botterweck, M Dirx, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 2012
Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?D De Ruysscher, J Van Meerbeeck, K Vandecasteele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2010
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)C Le Péchoux, A Laplanche, C Faivre-Finn, et al.
Prenatal Diagnosis|September 3, 2010
Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirthC G Steward, R A Newbury-Ecob, R Hastings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2007
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patientsD De Ruysscher, C Dehing, R-H Bremer, et al.
Pageof 2